NAFLD

Truong E, Alnimer L, Gornbein JA, Yang JD, Alkhouri N, Harrison SA, Noureddin M. Agile 3+ and 4 Scores Accurately Predict Major Adverse Liver Outcomes,[...]

By sjmartinez • March 25, 2025

Bazargan-Hejazi S, Hines C, Usmani M, Argueta C, Pan D, Brown AF. Racial Disparities in Mortality Rates among Patients with Hepatic Steatosis, Non-Alcoholic Fatty Liver[...]

By sjmartinez • March 5, 2025

Higa R, Pourteymour S, Kolan PS, Dankel SN, Fernø J, Mellgren G, Pan C, Seldin MM, Lusis AJ, Drevon CA, Dalen KT, Norheim FA. Hepatic[...]

By sjmartinez • February 28, 2025

Danpanichkul P, Suparan K, Dutta P, Kaeosri C, Sukphutanan B, Pang Y, Kulthamrongsri N, Jaisa-Aad M, Ng CH, Teng M, Nakano M, Morishita A, Alkhouri[...]

By sjmartinez • June 29, 2024

Steiger A, VanderVeen NT, Kang EH, Weimer AK. Resolution of metabolic dysfunction-associated steatohepatitis with estradiol in a transgender female: A case report. JPGN Rep. 2024 Feb[...]

By sjmartinez • May 17, 2024

Singh J, Ibrahim B, Jackson NJ, Khalil H, Valenzuela J, Yanny B, Saab S. Lower FIB-4 threshold in patients with diabetes improves diagnostic accuracy of[...]

By sjmartinez • May 8, 2024

Chow KW, Futela P, Saharan A, Saab S. Comparison of Guidelines for the Screening, Diagnosis, and Noninvasive Assessment of Nonalcoholic Fatty Liver Disease. J Clin[...]

By sjmartinez • September 11, 2023

Truong E, Gornbein JA, Yang JD, Noureddin N, Harrison SA, Alkhouri N, Noureddin M. MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma,[...]

By sjmartinez • August 28, 2023

Liang JX, Ampuero J, Niu H, Imajo K, Noureddin M, Behari J, Lee DH, Ehman RL, Rorsman F, Vessby J, Lacalle JR, Mózes FE, Pavlides[...]

By sjmartinez • August 22, 2023

Park SH, Helsley RN, Fadhul T, Willoughby JLS, Noetzli L, Tu HC, Solheim MH, Fujisaka S, Pan H, Dreyfuss JM, Bons J, Rose J, King[...]

By sjmartinez • May 26, 2023